Cargando…
Research Progress of Biomarkers for Immune Checkpoint Inhibitors on Digestive System Cancers
Immunotherapy represented by immune checkpoint inhibitors has gradually entered a new era of precision medicine. In view of the limited clinical benefits of immunotherapy in patients with digestive system cancers, as well as the side-effects and high treatment costs, development of biomarkers to pre...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043345/ https://www.ncbi.nlm.nih.gov/pubmed/35493526 http://dx.doi.org/10.3389/fimmu.2022.810539 |